PLEASE FIND BELOW THE AGENDA FOR LSPN EUROPE 2017.
Wednesday, December 6, 2017
8:00 AM - 8:30 AMRegistration, Welcome Coffee and Networking   
8:30 AM - 8:45 AMChairman's Opening Address
Peter Scott, Group Publisher, Life Sciences IP Review
 
9:00 AM - 9:30 AMGLOBAL INSIGHT

Global Patent Protection: Market Status and Outlook

  • Recent Case Law Round-up and Policy Direction

Charles Larson, Partner, White & Case

Anita Varma, Partner, White & Case

 
9:30 AM - 9:50 AMEUROPE FOCUS

What is the Scope of my Patent in Europe?

  • Claim interpretation in view of the UK Supreme Court’s decision in Actavis v Lilly

  • Doctrine of equivalents and the relevance of the file history

  • What next? How broadly does the new test extend, will other European courts agree, and will the UPC help?

 

Hazel Ford, Partner, Finnegan Europe

 
9:50 AM - 10:20 AMPANEL DISCUSSION

Supplementary Protection Certificates: Current Status and Future Developments

  • Does the unitary patent require a unitary SPC?

  • Can a unitary SPC be granted in any event with it taking effect only in the markets where there is a patent?

  • The EU is looking again at ‘Bolar exemptions’ for the EU: are they broadening/narrowing or are they just right?

  • The EU is looking at a manufacturing exemption under SPC for stockpiling and export: what are your thoughts?

Moderator: 

Hazel Ford, Partner, Finnegan Europe

Panellists:

Sven Bostyn , Senior lecturer in IP law, University of Liverpool

 

Andrew Brown, Head of IP, Aspire Pharma

Glyn Truscott, Partner, Elkington + Fife

 
10:20 AM - 10:35 AMTRADEMARKS FOCUS
Addressing Trademark Infringement
  • How do we police grey market sales?
  • Multi-jurisdictional branding: How do you choose the right name to protect against infringement?
Ruth Hoy, Partner, DLA Piper
 
10:35 AM - 11:05 AMMORNING COFFEE AND NETWORKING  
11:05 AM - 11:25 AMSECOND MEDICAL USE

Second Medical Use: Addressing Second Medical Use Infringement 

Marianne Schaffner, Partner, Dechert

 
11:25 AM - 11:45 AMSECOND MEDICAL USE

Protecting Second Medical Uses

Ewan Nettleton, Senior patent counsel, Oncology, Novartis Pharma

 
 
 
11:45 AM - 12:15 PMSECOND MEDICAL USE PANEL DISCUSSION

Sven Bostyn , Senior Lecturer in Intellectual Property Law, University of Liverpool

Ewan Nettleton, Senior Patent Counsel, Oncology, Novartis Pharma

Marianne Schaffner, Partner, Dechert

 
12:15 PM - 12:35 PMCRISPR FOCUS
CRISPR: Disseminating Scientific Innovation
  • Licensing CRISPR: Principles and Opportunities
Issi Rozen, Chief Business Officer, The Broad Institute of MIT & Harvard
 
12:35 PM - 1:00 PMCRISPR PANEL DISCUSSION
How do we Balance the Practical, Legal and Ethical Considerations of Gene Editing?
 
Issi Rozen, Chief Business Officer, The Broad Insitute of MIT & Harvard
Timo Minssen, Professor of Law and Managing Director, Centre for Advanced Studies in Biomedical Innovation Law
Catherine Coombes, Patent Director, HGF
 
1:00 PM - 1:55 PMLunch and Networking in the Exhibition Hall  
1:55 PM - 2:00 PMROUNDTABLE DISCUSSIONS
Please select your preferred roundtable topic for each rotation. We will endeavour to place you on your preffered table, however places will be allocated on a first come first served basis.
 
2:00 PM - 2:45 PMRotation 1 - IP Considerations in M&A
Kevin Fournier, Counsel - Intellectual Property Law, IBM
ROUNDTABLE
2:00 PM - 2:45 PMRotation 1 - Life Sciences Patent Open Clinic: Solving in-house Counsel Challenges
Will James, Partner, Marks & Clerk
Will Nieuwenhuys, Partner, Marks & Clerk
ROUNDTABLE
2:00 PM - 2:45 PMRotation 1 - Strategies in Second Medical Use Cases
Christopher Wilkins, European Patent Attorney, Dehns
ROUNDTABLE
2:00 PM - 2:45 PMRotation 1 - Licensing Considerations ROUNDTABLE
2:00 PM - 2:45 PMRotation 1 - The UK now has a Doctrine of Equivalents: How will this affect us?
Douglas Drysdale, Partner, HGF
ROUNDTABLE
2:00 PM - 2:45 PMRotation 1 - Navigating the CRISPR Patent Licensing Landscape
Catherine Coombes, Patent Director, HGF
ROUNDTABLE
2:00 PM - 2:45 PMRotation 1 - Best Practice in IP Portfolio Management
Glyn Truscott, Partner, Elkington + Fife
ROUNDTABLE
2:00 PM - 2:45 PMRotation 1 - Brexit Considerations: Pragmatic Steps for your Portfolio
Sally Shorthose, Partner, Bird & Bird
ROUNDTABLE
2:45 PM - 3:30 PMRotation 2 - The UK now has a Doctrine of Equivalents: How will this affect us?
Douglas Drysdale, Partner, HGF
ROUNDTABLE
2:45 PM - 3:30 PMRotation 2 - Life Sciences Patent Open Clinic: Solving in-house Counsel Challenges
Will James, Partner, Marks & Clerk
Will Nieuwenhuys, Partner, Marks & Clerk
ROUNDTABLE
2:45 PM - 3:30 PMRotation 2 - Licensing Considerations ROUNDTABLE
2:45 PM - 3:30 PMRotation 2 - Best Practice in IP Portfolio Management
Glyn Truscott, Partner, Elkington + Fife
ROUNDTABLE
2:45 PM - 3:30 PMRotation 2 - IP Considerations in M&A
Kevin Fournier, Counsel - Intellectual Property Law, IBM
ROUNDTABLE
2:45 PM - 3:30 PMRotation 2 - Strategies in Second Medical Use Cases
Christopher Wilkins, European Patent Attorney, Dehns
ROUNDTABLE
2:45 PM - 3:30 PMRotation 2 - Navigating the CRISPR Patent Licensing Landscape
Catherine Coombes, Patent Director, HGF
ROUNDTABLE
2:45 PM - 3:30 PMRotation 2 - Brexit Considerations: Pragmatic Steps for your Portfolio
Sally Shorthose, Partner, Bird & Bird
ROUNDTABLE
3:30 PM - 3:45 PMROUNDTABLE ROUND UP
Key findings and points of note
 
3:45 PM - 4:00 PMAfternoon Tea and Networking in the Exhibition Hall  
4:00 PM - 4:20 PMSTANDARDS

Best Practice in Harnessing Intellectual Property

Kevin Fournier, Counsel - Intellectual Property Law, IBM

 
 
4:20 PM - 4:40 PMSTANDARDS

Empirical Data & an Evidence-Based Approach in Policy Design

  • Understanding Patent Activities Broadly

  • Making Sound Policy Decisions Starts with Understanding Patent Systems

Axel Ferrazzini, Managing Director, 4iP Council EU

 
4:40 PM - 5:00 PMIP PORTFOLIO MANAGEMENT

IP Portfolio Management: Corporate Counsel Case Study

Best Practice and Day-to-Day Challenges in Operating an Effective Patent Portfolio

  •  Internal Business Alignment: Matching Commercial Expectations with your Current Patent Status

  • Licensing Considerations and Opportunities


Maria Nichol, VP, Intellectual Property, Galapagos
 
5:00 PM - 5:30 PMIN-HOUSE COUNSEL PANEL DISCUSSION
In-House Counsel Share Legal Challenges: Securing and Protecting Patents
  • What are the day-to-day challenges for in house counsel in securing IP rights?
  • What do we need from private practice attorneys?
  • Infringement: What should be our strategy in patent enforcement?

Maria Nichol, VP, Intellectual Property, Galapagos

Martyn Andrews, Head of IP, Oxford Nanopore Technologies

Steve Ward. Lead Patent Attorney, Syngenta

 
5:45 PM - 7:00 PMCHAIRMAN'S CLOSING REMARKS AND DRINKS RECEPTION